Novo Nordisk A/S (NVO)
37.96
-0.06
(-0.16%)
USD |
NYSE |
Mar 13, 16:00
37.98
+0.02
(+0.05%)
Pre-Market: 20:00
Novo Nordisk Shareholders Equity (Quarterly) : 30.51B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ascendis Pharma A/S | -191.23M |
| Evaxion AS | 16.60M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Viking Therapeutics, Inc. | 639.06M |
| DBV Technologies SA | 52.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.37B |
| Total Liabilities (Quarterly) | 54.85B |
| Debt to Equity Ratio | 0.6749 |
| Current Ratio | 0.7996 |
| Net Debt Paydown Yield | -1.07% |